Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...
Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, tissue-targeted medicines, today ...
Hosted on MSN3h
Is there a vaccine for H5N1? What we know as first person with severe case of bird flu died in United StatesThe H5N1 bird flu has been reported to have caused the death of a patient in Louisiana. Such a case poses a significant ...
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...
RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...
The global pediatric vaccine market is set for unprecedented growth, with a valuation of US$ 54,130.1 million in 2023, ...
Anya Polytech & Fertilizers' IPO received strong interest, being subscribed 18.76 times by Day 2, with robust demand from retail and non-institutional investors. The company aims to raise Rs 44.80 ...
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...
While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback